Albireo Ready To Seek Second Bylvay Indication In Alagille Syndrome

Phase III Success Will Support Filing

 
• By Joseph Haas
LFTs
Albireo hopes to add a second rare liver disease to Bylvay's label • Source: Shutterstock

More from Strategy

More from Business